Closed · RFA-HL-10-016 · CFDA 93.838 · Discretionary

Lung Transplantation: Planning Grants for Clinical Trials of Novel Therapies (R34)

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

up to $450K
Award range
Closed
Status
February 3, 2010
Close date
-
Expected awards

The verdict

Lung Transplantation: Planning Grants for Clinical Trials of Novel Therapies (R34) is a closed discretionary listing from National Institutes of Health that offered Up to $450,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.

up to $450K
award range
Closed
application status
93.838
CFDA program
12,419
other opportunities from National Institutes of Health

Archived opportunity record

Lung Transplantation: Planning Grants for Cli… is closed (last close February 3, 2010). The parent program page for CFDA 93.838 is the reliable place to catch re-announcements. National Institutes of Health still indexes 12,419 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed February 3, 2010

Posted Sep 30 Closes Feb 3

Est. Total Funding

$1,500,000

Instrument

Grant

Description

Purpose. The National Heart, Lung, and Blood Institute (NHLBI) invites applications to support the initial organization, protocol development, and necessary preliminary studies critical for the design of robust clinical trials in lung transplantation. This Funding Opportunity Announcement (FOA) should be used to position investigators or groups of investigators to develop competitive clinical trials to test important new strategies to enhance the quality of lungs available for transplant and improve management and long term outcomes of lung transplant recipients. This may include assembling a research team, consisting of a principal clinical site and having several collaborating ancillary sites, defining and prioritizing research questions, collecting information on the feasibility of the therapy and patient availability, and developing protocol(s). Applications must demonstrate that the proposed work is both necessary and sufficient to permit proceeding to the design of important clinical trial(s). During the evaluation of applications in response to this FOA, the review group will also consider the significance and potential impact of the full-scale clinical trial(s) that would be proposed following the R34 award period. Of most importance, the NHLBI anticipates that the R34 award period will yield competitive investigator-initiated clinical trial grant applications that evaluate interventions for the treatment of complications during and after lung transplantation. Mechanism of Support. This FOA will utilize the R34 grant mechanism. Funds Available and Anticipated Number of Awards. The NHLBI intends to commit approximately $1,500,000 total costs for FY2010. The total amount to be awarded for this program will be a maximum of $3,000,000 total costs for the 2-year project period. It is anticipated that NHLBI will fund up to 2 awards.

Wide-open applicant board · 15 Grants.gov doors

Lung Transplantation: Planning Grants for Cli… prints 15 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +11 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). This eligibility-code string dominates the National Institutes of Health book (9,741 peers, 78% of 12,420).

Code 00
State governments
Code 01
County governments
Code 02
City or township governments
Code 04
Special district governments
Code 05
Independent school districts
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 08
Public / Indian housing authorities
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 23
Small businesses
Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

What to do next

Lung Transplantation: Planning Grants for Cli… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.838 may publish future NOFOs under the same assistance listing. Open program
  • Lung Disease Research indexes 90 Grants.gov listings in this extract. Program profile
  • National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants